Skip to main content
Toggle navigation
Login
Search
Home
Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
G
Gadkar, Kapil
Genentech
Convergence of QSP and Pharmacometrics - Are we there yet?
Location: Sonoran Sky Ballroom 1 - 4
Kapil Gadkar
Favorite
Mind the gap – successful bridging of QSP and PMX in drug development
Location: Sonoran Sky Ballroom 1 - 4
Kapil Gadkar
Favorite
Panel Discussion
Location: Sonoran Sky Ballroom 1 - 4
Kapil Gadkar
Favorite
Galetin, Aleksandra
University of Manchester
Application of endogenous biomarkers of drug transporters and liquid biopsy coupled with PBPK modelling to support precision dosing in renal impairment
Location: Sonoran Sky Ballroom 5 - 8
Aleksandra Galetin
Favorite
Integration of modelling, endogenous biomarkers, and real-world study approaches to support precision dosing in special populations
Location: Sonoran Sky Ballroom 5 - 8
Aleksandra Galetin
Favorite
Panel Discussion
Location: Sonoran Sky Ballroom 5-8
Aleksandra Galetin
Favorite
Gao, Wei
Moderna
ACoP 2024 Opening Session
Location: Canyon Ballroom
Wei Gao
Favorite
Closing General Session
Location: Canyon Ballroom
Wei Gao
Favorite
Fireside Chat - Charting New Frontiers: CDER's Quantitative Medicine Center of Excellence
Location: Canyon Ballroom
Wei Gao
Favorite
Welcome to ACoP 2024
Location: Canyon Ballroom
Wei Gao
Favorite
Garimella, Tushar
Daiichi Sankyo Inc
Challenges in characterizing treatment response in oncology - Pitfalls and solutions
Location: Sonoran Sky Ballroom 1 - 4
Tushar Garimella
Favorite
Dose Selection and Optimization in Oncology: Focus on ADCs
Location: Sonoran Sky Ballroom 1 - 4
Tushar Garimella
Favorite
Gertz, Michael
F. Hoffmann-La Roche
Estimation of FMO3 Ontogeny by Mechanistic Population Pharmacokinetic Modelling of Risdiplam and Its Impact on Drug–Drug Interactions in Children
Location: Sonoran Sky Ballroom 5 - 8
Michael Gertz
Favorite
Integration of modelling, endogenous biomarkers, and real-world study approaches to support precision dosing in special populations
Location: Sonoran Sky Ballroom 5 - 8
Michael Gertz
Favorite
Panel Discussion
Location: Sonoran Sky Ballroom 5-8
Michael Gertz
Favorite
Gillespie, Bill
METRUM001 - Efficient reproducible Bayesian population PK modeling with NONMEM and Stan/Torsten, Metrum Research Group
Location: Mesquite
Bill Gillespie
Favorite
METRUM002 - Efficient reproducible Bayesian population PK modeling with NONMEM and Stan/Torsten, Metrum Research Group
Location: Mesquite
Bill Gillespie
Favorite
Glassman, Fiona
Biogen
Roller Coaster 2
Location: Sonoran Sky Ballroom 1-4
Fiona Glassman
Favorite
Gobburu, Joga
University of Maryland
Is Pharmacometrics limited by the industry settings?
Location: Kaibab & Lantana
Joga Gobburu
Favorite
Panel Discussion
Location: Kaibab & Lantana
Joga Gobburu
Favorite
Roller Coaster 1
Location: Canyon Ballroom
Joga Gobburu
Favorite
Transforming Healthcare with Large Language Models: Opportunities and challenges
Location: Canyon Ballroom
Joga Gobburu
Favorite
Gong, Jingqi
GlaxoSmithKline
Advancing QSP: From Virtual Patient To Digital Twin
Location: Kaibab & Lantana
Jingqi Gong
Favorite
Panel Discussion
Location: Kaibab & Lantana
Jingqi Gong
Favorite
Gong, Yuqing
Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Next generation M&S packages deployable and accessible for MIDD and Model Integrated Evidence - Advances Through GDUFA-Sponsored Research
Location: Sonoran Sky Ballroom 5 - 8
Yuqing Gong
Favorite
Goulooze, Sebastiaan
LAP&P Consultants BV
Overadjustment bias and mediation analysis in PK/PD modeling
Location: Sonoran Sky Ballroom 5 - 8
Sebastiaan Goulooze
Favorite
Roller Coaster 3
Location: Sonoran Sky Ballroom 5 - 8
Sebastiaan Goulooze
Favorite
Goyal, Navin
Johnson and Johnson
Roller Coaster 3
Location: Sonoran Sky Ballroom 5 - 8
Navin Goyal
Favorite
Greene, Stephen
ACoP Special Session-The Future is Now: Envisioning the Next Era of Pharmacometrics
Location: Canyon Ballroom
Stephen Greene
Favorite
Green, Seth
METRUM001 - Efficient reproducible Bayesian population PK modeling with NONMEM and Stan/Torsten, Metrum Research Group
Location: Mesquite
Seth Green
Favorite
METRUM002 - Efficient reproducible Bayesian population PK modeling with NONMEM and Stan/Torsten, Metrum Research Group
Location: Mesquite
Seth Green
Favorite
Gueorguieva, Ivelina
Eli Lilly and Company
Enabling Progress Against Alzheimer's Disease: Power of Diverse Pharmacometrics Approaches
Location: Canyon Ballroom
Ivelina Gueorguieva
Favorite
Model Informed Drug Development (MIDD) in Alzheimer’s Disease
Location: Canyon Ballroom
Ivelina Gueorguieva
Favorite
Panel Discussion
Location: Canyon Ballroom
Ivelina Gueorguieva
Favorite
Gumbo, Tawanda
CEO, Phase Advance AI
AI-aided Virtual Disease Progression Clinical trials – the marriage of nonlinear mathematical modeling, biology, and AI in predicting future individual patient responses in global health
Location: Canyon Ballroom
Tawanda Gumbo
Favorite
General Session: President's Address and State-of-the-Art Lecture
Location: Canyon Ballroom
Tawanda Gumbo
Favorite
Gunawan, Rudy
Pfizer
Dose Optimization of ADCs
Location: Canyon Ballroom
Rudy Gunawan
Favorite
Quantitative clinical pharmacology of antibody drug conjugate development: challenges and opportunities
Location: Canyon Ballroom
Rudy Gunawan
Favorite
